Howard Emerging Group

The current clinically approved mRNA vaccines are packaged in Lipid Nanoparticles (LNPs), and biodistribution studies show that upon injection there is significant off-target effects where most of the LNPs are taken up by local muscle cells, while a residual portion reaches the blood stream to en

COVID-19, COVID-19 variants and Influenza are critical pandemic threat pathogens and their monitoring and rapid sensitive detection in the community is vital.